121 related articles for article (PubMed ID: 37961007)
1. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
Kwak N; Lee H; Kim BK; Yu YM; Kang HY
J Gastroenterol Hepatol; 2024 Feb; 39(2):280-288. PubMed ID: 37961007
[TBL] [Abstract][Full Text] [Related]
2. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study.
Lin WT; Liao YJ; Peng YC; Chang CH; Lin CH; Yeh HZ; Chang CS
World J Gastroenterol; 2017 May; 23(19):3513-3521. PubMed ID: 28596687
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder.
Chen VC; Lee MJ; Yang YH; Lu ML; Chiu WC; Dewey ME
Drug Alcohol Depend; 2021 Feb; 219():108495. PubMed ID: 33429293
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
Czaja AS; Valuck RJ; Anderson HD
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
[TBL] [Abstract][Full Text] [Related]
6. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
[TBL] [Abstract][Full Text] [Related]
7. Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan.
Cheng YL; Hu HY; Lin XH; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
Medicine (Baltimore); 2015 Nov; 94(46):e2022. PubMed ID: 26579809
[TBL] [Abstract][Full Text] [Related]
8. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
9. Selective Serotonin Reuptake Inhibitors and Poststroke Epilepsy: A Population-Based Nationwide Study.
Chou CC; Yen DJ; Lin YY; Wang YC; Lin CL; Kao CH
Mayo Clin Proc; 2017 Feb; 92(2):193-199. PubMed ID: 28160872
[TBL] [Abstract][Full Text] [Related]
10. Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis.
Chen KH; Wang TY; Lee CP; Yang YH; McIntyre RS; Subramaniapillai M; Lee Y; Chen VC
Medicine (Baltimore); 2022 May; 101(18):e29202. PubMed ID: 35550469
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.
Bundeff AW; Woodis CB
Ann Pharmacother; 2014 Jun; 48(6):777-84. PubMed ID: 24651166
[TBL] [Abstract][Full Text] [Related]
12. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
[TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
[TBL] [Abstract][Full Text] [Related]
14. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitor-induced urinary incontinence.
Movig KL; Leufkens HG; Belitser SV; Lenderink AW; Egberts AC
Pharmacoepidemiol Drug Saf; 2002 Jun; 11(4):271-9. PubMed ID: 12138594
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients.
Chang CM; Hsieh MS; Yang TC; Hsieh VC; Chiang JH; Huang HH; How CK; Hu SY; Yen DH
Cancer Manag Res; 2017; 9():709-720. PubMed ID: 29238221
[TBL] [Abstract][Full Text] [Related]
18. Association between selective serotonin reuptake inhibitors and kidney cancer risk: A nationwide population-based cohort study.
Lee MJ; Huang CW; Chen YL; Yang YH; Chen VC
Int J Cancer; 2021 Mar; 148(6):1331-1337. PubMed ID: 32965039
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.
Xie C; Tang Y; Wang Y; Yu T; Wang Y; Jiang L; Lin L
PLoS One; 2015; 10(8):e0127815. PubMed ID: 26252008
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
Eke AC; Saccone G; Berghella V
BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
